Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CGNX Stock Summary
Top 10 Correlated ETFs
CGNX
In the News

Cognex: Missing The 'Vision' In This Vision Play
Cognex Corporation, a machine vision company, has been underperforming despite its strong positioning in the industry. Revenues have been flat in recent years, and the company's stock price has been range-bound. The acquisition of Moritex is expected to add 6-8% to total sales, but the deal is not expected to be accretive until 2025.

5 Computer Vision Stocks with a Clear Path to Growth
AI is hot; today's craze is just the tip of the iceberg. While large language models, generative AI, and image-producing algorithms are neat, the next phase of AI will start generating cash flow for companies other than NVIDIA NASDAQ: NVDA and the data center group in which generative AI is grounded.

Top 5 Tech Stocks Which Could Rescue Your Portfolio This Month - Cognex (NASDAQ:CGNX), Apple (NASDAQ:AAPL)
The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.

Cognex Announces Second Quarter Earnings Release Date and Conference Call
NATICK, Mass.--(BUSINESS WIRE)--Cognex announces second quarter earnings release date and conference call.

3 Red-Hot Nasdaq Stocks That Are Leading Industrial Automation, Robotics, and AI
PTC has tons of upside in the years to come. There's a lot to like about Cognex, except for its valuation.

Cognex: Automation Leader Leveraging AI
Cognex's financial performance is currently weak as customers are generally cutting back on capital expenditures. Despite this challenge, the manufacturing investment boom in the US should support the business. Given current headwinds, the stock appears fully valued, but investors may not get a much better entry point.

A Bull Market Is Coming: 2 Artificial Intelligence (AI) Growth Stocks Down 41% and 51% to Buy Now
Artificial intelligence could add $13 trillion to global economic output by 2030. Datadog is a leader in several observability software verticals but the company has hardly scratched the surface of its addressable market.

Cognex: Soft Performance Despite A Strong Positioning
Cognex has been well positioned to benefit from increased machine vision applications in industrial, e-commerce and logistics settings. I like the promise of the business, but the overall performance has been a bit soft. Amidst shares outperforming the actual performance of the business, I am inclined to take some profits here, not convinced on the execution part of the story.

Cognex Announces Participation at Upcoming Investor Conferences
NATICK, Mass.--(BUSINESS WIRE)--Cognex announces participation at upcoming investor conferences.

Dividend Champion, Contender, And Challenger Highlights: Week Of May 14
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
CGNX Financial details
CGNX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 4.68 | 4.24 | 4.67 | 5.88 | 5.8 | |
Net income per share | 1.27 | 1.19 | 1.02 | 1.59 | 1.24 | |
Operating cash flow per share | 1.3 | 1.48 | 1.4 | 1.78 | 1.4 | |
Free cash flow per share | 1.08 | 1.35 | 1.32 | 1.69 | 1.29 | |
Cash per share | 7.11 | 6.34 | 2.15 | 5.92 | 6.19 | |
Book value per share | 6.59 | 7.92 | 7.28 | 8.1 | 8.29 | |
Tangible book value per share | 5.87 | 6.27 | 5.78 | 6.67 | 6.82 | |
Share holders equity per share | 6.59 | 7.92 | 7.28 | 8.1 | 8.29 | |
Interest debt per share | 0.03 | 0.14 | 0.15 | 0.19 | 0.37 | |
Market cap | 6.66B | 9.59B | 13.93B | 13.72B | 8.17B | |
Enterprise value | 5.87B | 8.77B | 13.69B | 12.84B | 7.36B | |
P/E ratio | 30.39 | 47.06 | 79.06 | 49.03 | 37.9 | |
Price to sales ratio | 8.26 | 13.22 | 17.18 | 13.23 | 8.12 | |
POCF ratio | 29.82 | 37.89 | 57.46 | 43.69 | 33.56 | |
PFCF ratio | 35.76 | 41.45 | 60.8 | 45.95 | 36.51 | |
P/B Ratio | 5.87 | 7.08 | 11.04 | 9.6 | 5.68 | |
PTB ratio | 5.87 | 7.08 | 11.04 | 9.6 | 5.68 | |
EV to sales | 7.28 | 12.08 | 16.88 | 12.38 | 7.32 | |
Enterprise value over EBITDA | 28.24 | 71.73 | 54.46 | 41.25 | 25.69 | |
EV to operating cash flow | 26.25 | 34.62 | 56.46 | 40.88 | 30.25 | |
EV to free cash flow | 31.48 | 37.87 | 59.74 | 43 | 32.91 | |
Earnings yield | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 | |
Free cash flow yield | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | |
Debt to equity | 0 | 0.02 | 0.02 | 0.02 | 0.03 | |
Debt to assets | 0 | 0.01 | 0.01 | 0.02 | 0.02 | |
Net debt to EBITDA | -3.84 | -6.77 | -0.97 | -2.83 | -2.81 | |
Current ratio | 6.7 | 6.19 | 4.55 | 4.82 | 4.83 | |
Interest coverage | 0 | 0 | 0 | 0 | 15.09 | |
Income quality | 1.02 | 1.24 | 1.38 | 1.12 | 1.13 | |
Dividend Yield | 0 | 0 | 0.03 | 0 | 0.01 | |
Payout ratio | 0.15 | 0.17 | 2.22 | 0.15 | 0.21 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.14 | 0.16 | 0.16 | 0.13 | 0.14 | |
Intangibles to total assets | 0.1 | 0.15 | 0.14 | 0.13 | 0.13 | |
Capex to operating cash flow | -0.17 | -0.09 | -0.05 | -0.05 | -0.08 | |
Capex to revenue | -0.05 | -0.03 | -0.02 | -0.01 | -0.02 | |
Capex to depreciation | -1.72 | -0.87 | -0.5 | -0.76 | -1 | |
Stock based compensation to revenue | 0.05 | 0.06 | 0.05 | 0.04 | 0.05 | |
Graham number | 13.73 | 14.57 | 12.89 | 17.01 | 15.23 | |
ROIC | 0.18 | 0.09 | 0.12 | 0.19 | 0.14 | |
Return on tangible assets | 0.19 | 0.13 | 0.11 | 0.16 | 0.13 | |
Graham Net | 7.01 | 3.87 | -0.21 | 3.55 | 4.09 | |
Working capital | 857.83M | 845.99M | 469.39M | 912.07M | 874.02M | |
Tangible asset value | 1.01B | 1.07B | 1B | 1.18B | 1.18B | |
Net current asset value | 853.96M | 478.84M | 63.19M | 577.25M | 582.4M | |
Invested capital | 0 | 0.02 | 0.02 | 0.02 | 0.03 | |
Average receivables | 127.16M | 115.47M | 117.39M | 130.84M | 127.88M | |
Average payables | 84.08M | 73.26M | 43.17M | 76.38M | 128.41M | |
Average inventory | 75.6M | 71.77M | 60.55M | 86.97M | 117.79M | |
Days sales outstanding | 57.71 | 52.04 | 59.1 | 45.88 | 45.5 | |
Days payables outstanding | 135.42 | 134.77 | 28.77 | 179.67 | 154.56 | |
Days of inventory on hand | 147.53 | 115.91 | 107.56 | 148.89 | 157.31 | |
Receivables turnover | 6.33 | 7.01 | 6.18 | 7.96 | 8.02 | |
Payables turnover | 2.7 | 2.71 | 12.69 | 2.03 | 2.36 | |
Inventory turnover | 2.47 | 3.15 | 3.39 | 2.45 | 2.32 | |
ROE | 0.19 | 0.15 | 0.14 | 0.2 | 0.15 | |
Capex per share | -0.22 | -0.13 | -0.08 | -0.09 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-07-02 for Q2
Metric | History | 2022-07-03 | 2022-10-02 | 2022-12-31 | 2023-04-02 | 2023-07-02 |
---|---|---|---|---|---|---|
Revenue per share | 1.58 | 1.21 | 1.39 | 1.17 | 1.41 | |
Net income per share | 0.34 | 0.2 | 0.32 | 0.15 | 0.33 | |
Operating cash flow per share | 0.25 | 0.48 | 0.38 | 0.16 | 0.17 | |
Free cash flow per share | 0.22 | 0.46 | 0.36 | 0.13 | 0.15 | |
Cash per share | 2.07 | 5.92 | 6.21 | 2.21 | 2.14 | |
Book value per share | 8.01 | 8.02 | 8.33 | 8.38 | 8.59 | |
Tangible book value per share | 6.57 | 6.59 | 6.85 | 6.91 | 7.12 | |
Share holders equity per share | 8.01 | 8.02 | 8.33 | 8.38 | 8.59 | |
Interest debt per share | 0.37 | 0.35 | 0.22 | 0.21 | 0.41 | |
Market cap | 7.54B | 7.53B | 8.14B | 8.51B | 9.66B | |
Enterprise value | 7.4B | 6.77B | 7.33B | 8.38B | 9.55B | |
P/E ratio | 32.01 | 55.37 | 36.77 | 83.01 | 42 | |
Price to sales ratio | 27.46 | 35.9 | 33.98 | 42.29 | 39.82 | |
POCF ratio | 170.98 | 90.11 | 122.79 | 308.68 | 323.5 | |
PFCF ratio | 201.43 | 95.07 | 130.81 | 385.79 | 383.95 | |
P/B Ratio | 5.43 | 5.42 | 5.66 | 5.88 | 6.52 | |
PTB ratio | 5.43 | 5.42 | 5.66 | 5.88 | 6.52 | |
EV to sales | 26.94 | 32.28 | 30.61 | 41.67 | 39.37 | |
Enterprise value over EBITDA | 74.92 | 145.59 | 136.42 | 362.67 | 165.53 | |
EV to operating cash flow | 167.74 | 81.03 | 110.62 | 304.16 | 319.9 | |
EV to free cash flow | 197.62 | 85.48 | 117.85 | 380.14 | 379.68 | |
Earnings yield | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Free cash flow yield | 0 | 0.01 | 0.01 | 0 | 0 | |
Debt to equity | 0.02 | 0.04 | 0.03 | 0.03 | 0.05 | |
Debt to assets | 0.02 | 0.03 | 0.02 | 0.02 | 0.04 | |
Net debt to EBITDA | -1.45 | -16.33 | -15 | -5.39 | -1.86 | |
Current ratio | 3.82 | 4.41 | 4.83 | 3.37 | 3.98 | |
Interest coverage | 3.18 | 17.63 | -5.18 | -5.47 | 0 | |
Income quality | 0.75 | 2.46 | 1.2 | 1.08 | 0.52 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.19 | 0.33 | 0.22 | 0.47 | 0.21 | |
Sales general and administrative to revenue | 0.3 | 0.38 | 0 | 0 | 0 | |
Research and developement to revenue | 0.12 | 0.16 | 0.16 | 0.19 | 0.14 | |
Intangibles to total assets | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | |
Capex to operating cash flow | -0.15 | -0.05 | -0.06 | -0.2 | -0.16 | |
Capex to revenue | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 | |
Capex to depreciation | -1.38 | -0.89 | -0.82 | -1.12 | -0.95 | |
Stock based compensation to revenue | 0.05 | 0.06 | 0.05 | 0.08 | 0.05 | |
Graham number | 7.82 | 5.95 | 7.75 | 5.29 | 8.02 | |
ROIC | 0.06 | 0.02 | 0.03 | 0.01 | 0.03 | |
Return on tangible assets | 0.03 | 0.02 | 0.03 | 0.01 | 0.03 | |
Graham Net | -0.09 | 3.7 | 4.1 | 0.15 | 0.16 | |
Working capital | 542.52M | 790.73M | 874.02M | 508.19M | 537.92M | |
Tangible asset value | 1.14B | 1.14B | 1.18B | 1.19B | 1.23B | |
Net current asset value | 181.66M | 511.46M | 582.4M | 194.43M | 200.73M | |
Invested capital | 0.02 | 0.04 | 0.03 | 0.03 | 0.05 | |
Average receivables | 165.3M | 134.99M | 110.85M | 135.96M | 148.31M | |
Average payables | 32.55M | 53.35M | 103.34M | 73.64M | 26.52M | |
Average inventory | 116.34M | 102.28M | 115.52M | 124.81M | 126.69M | |
Days sales outstanding | 56.92 | 41.34 | 47.14 | 65.56 | 55.71 | |
Days payables outstanding | 23.45 | 135.41 | 155.01 | 42.25 | 37.4 | |
Days of inventory on hand | 110.58 | 170.26 | 157.77 | 199.41 | 180.81 | |
Receivables turnover | 1.58 | 2.18 | 1.91 | 1.37 | 1.62 | |
Payables turnover | 3.84 | 0.66 | 0.58 | 2.13 | 2.41 | |
Inventory turnover | 0.81 | 0.53 | 0.57 | 0.45 | 0.5 | |
ROE | 0.04 | 0.02 | 0.04 | 0.02 | 0.04 | |
Capex per share | -0.04 | -0.03 | -0.02 | -0.03 | -0.03 |
CGNX Frequently Asked Questions
What is Cognex Corporation stock symbol ?
Cognex Corporation is a US stock , located in Natick of Ma and trading under the symbol CGNX
Is Cognex Corporation buy or a sell ?
11 stock analysts have 11 predictions with a medium analyst target price of $64.18. The lowest prediction is $41 and the highest is $92
What is CGNX stock prediction ?
What is Cognex Corporation stock quote today ?
Cognex Corporation stock price is $42.475 today.
Is Cognex Corporation stock public?
Yes, Cognex Corporation is a publicly traded company.